This proposal will validate magnetic resonance (MR) determined liver proton density fat fraction (PDFF) as a biomarker of liver fat content in obesity-associated non-alcoholic fatty liver disease (NAFLD). The purpose of this study is to determine if Magnetic Resonance Imaging (MRI) can measure the amount of fat within the liver. If MRI can accurately measure liver fat, it could become an important way of testing for non-alcoholic fatty liver disease (NAFLD).
The Evaluation of Magnetic Resonance (MR)-determined Proton Density Fat Fraction (PDFF) as a Biomarker in Obesity-Associated Non Alcoholic Fatty Liver Disease (NAFLD)
This project was funded by: NIH
The term of this project was: May 2011 to June 2015
The number of subjects scanned during this project was: 70